NASDAQ:NMTR
9 Meters Biopharma, Inc.
- Stock
locale
United Statesmarket
STOCKSindustry
Biotechnologywebsite
www.9meters.comipo date
Jul 11, 2016
9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders. The company is developing Larazotide, an 8-amino acid peptide, which is in Phase 3 clinical trial for the treatment of celiac disease, as well as in Phase IIa clinical trial...Show More
Earnings
Earnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus